PT - JOURNAL ARTICLE AU - Mary L. Adams AU - Joseph Grandpre AU - David L. Katz TI - Updated estimates of comorbidities associated with risk for COVID-19 complications based on US data AID - 10.1101/2020.05.02.20088781 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.02.20088781 4099 - http://medrxiv.org/content/early/2020/05/06/2020.05.02.20088781.short 4100 - http://medrxiv.org/content/early/2020/05/06/2020.05.02.20088781.full AB - We updated previous estimates (wwwnc.cdc.gov/eid/article/26/8/20-0679_article) of adults with any underlying condition increasing risk of complications from COVID-19 using recent US hospitalization data instead of mortality data from China. This substitutes obesity for cancer in the definition and increased the percentage of adults reporting ≥1 condition to 56.0% (95% CI 55.7-56.4). When controlled for all measures listed, factors increasing odds of reporting any of the underlying conditions include being male, older, African American, American Indian, household income <$25,000, < high school education, underinsurance, living in the South or Midwest (vs. West), plus the risk factors of ever smoking, sedentary lifestyle, and inadequate fruit and vegetable consumption. Population-attributable risk for the listed risk factors was 13.0%, 12.6%, and 15.0% respectively. Results have potential implications for policies based on risk-stratification of the population and for improvement of risk status through lifestyle change. National support for a “health promotion” campaign would be timely.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://wwwnc.cdc.gov/eid/article/26/8/20-0679_article Funding StatementData collection, analysis, and interpretation of data for this study were supported by the Centers for Disease Control and Prevention (CDC) Grant/Cooperative Agreement number 1U58DP006069-01Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSurvey data are available at: https://www.cdc.gov/brfss/annual_data/annual_2017.html https://www.cdc.gov/brfss/annual_data/annual_2017.html